Chitosan Sulfate Research Articles

Dual-function injectable fibrin gel incorporated with sulfated chitosan nanoparticles for rhBMP-2-induced bone regeneration

Bone fractures commonly occur in the aging patients, and exhibit slow fracture healing rates and high complication rates even with the best treatment strategies available. Additionally, aging patients always suffer from immunosenescence, and thus induce the dysfunction of macrophages to delay the bone repair. Although exogenous bone morphogenetic protein-2 (BMP-2) is verified that can efficiently promote bone regeneration, the supraphysiologic usage is always associated with abnormal heterotopic ossification and inflammatory response. Here, we have developed a dual-function injectable fibrin gel (Fg) with semisynthetic sulfated chitosan (SCS) nanoparticles (NPs) that significantly improves the recombinant human BMP-2 (rhBMP-2)-induced osteogenesis and down-regulates the inflammatory response at the fracture site. The prepared fibrinogen and sulfated chitosan nanoparticles (SCS NPs) efficiently prolong the delivery of rhBMP-2 and decrease the volume of bone callus. Moreover, SCS incorporated Fg regulates the macrophage polarization from pro-inflammatory M1 macrophage to anti-inflammatory M2 macrophage with a significant decrease of inflammatory-related cytokines. Finally, this dual-function injectable gel can also efficiently treat bone fractures well in postmenopausal mice with osteoporosis. Thus, this pro-osteogenic gel offers a translational potential for biomaterial-based bone healing.

Effect of sulfated chitosan hydrogel on vascularization and osteogenesis

Bone regeneration and vascularization have presented a clinical challenge for decades. Considering the importance of stem cells, such as mesenchymal stem cells (MSCs), in bone regeneration, endothelial progenitor cells (EPCs) are crucial during bone repair. This paper presented sulfated chitosan (SCS)-based hydrogel scaffolds to accelerate bone tissue regeneration, vascularization enhancement, and improve bone repair. Thus, these scaffolds played a crucial role in the regeneration of blood vessels, with the increased presentation of epithelial progenitors and immune cells in this microenvironment. In vivo experiments showed that the biological impact of SCS was critical for angiogenesis and vascularization, in conjunction with bone morphogenetic protein-2 (BMP-2) and MSCs. Therefore, the BMP-2-/hydrogel system established in this study promoted angiogenesis, stimulated MSC proliferation, and enhanced bone tissue formation. In addition, this paper highlighted the angiogenic role of SCS in creating a micro-environment for effective bone repair and provides insight into the future development of new bone regeneration material.

In Silico Analysis of Low Molecular Weight Sulfated Chitosan from <i>Sepia brevimana</i> as Potential Inhibitors of White Spot Syndrome Envelop Proteins

In Silico Analysis of Low Molecular Weight Sulfated Chitosan from <i>Sepia brevimana</i> as Potential Inhibitors of White Spot Syndrome Envelop Proteins

Selenide Chitosan Sulfate Improved the Hepatocyte Activity, Growth Performance, and Anti-oxidation Capacity by Activating the Thioredoxin Reductase of Chickens In Vitro and In Vivo.

Chicken hepatocytes were cultured in vitro and 240 specific pathogen-free (SPF) white leghorns chickens (7days old) were obtained. The hepatocytes and chickens were randomly allocated to one of six treatment groups: control group; chitosan (COS) group; sodium selenite (Na2SeO3) group; selenide chitosan (COS-Se) group; chitosan sulfate (LS-COS) group; and selenide chitosan sulfate (LS-COS-Se) group. Our results showed that LS-COS-Se increased (P < 0.05) the activities of thioredoxin reductase (TXNRD), anti-superoxide anion radical (antiO2-), and superoxide dismutase (SOD), the mRNA levels of thioredoxin reductase 1 (TXNRD1) and thioredoxin reductase 3 (TXNRD3), and the chicken body weight, but reduced (P < 0.05) the malondialdehyde (MDA) content and the lactate dehydrogenase (LDH) activity. Compared with COS and LS-COS, the LS-COS-Se treatment increased (P < 0.05) the activities of TXNRD, SOD, catalase (CAT), and the mRNA levels of TXNRD1 and TXNRD3, but reduced (P < 0.05) the MDA content in vitro, whereas, in vivo, it increased (P < 0.05) body weight on day 28; the activities of TXNRD, antiO2-, and SOD; and the mRNA levels of TXNRD1 and TXNRD3. Compared with Na2SeO3 and COS-Se, the LS-COS-Se treatment increased (P < 0.05) the TXNRD and SOD activities, the mRNA levels of TXNRD1 and TXNRD3 in vitro, increased (P < 0.05) the chicken body weight on day 28, and the TXNRD, antiO2-, and SOD activities, but reduced (P < 0.05) the MDA content. These results indicated that LS-COS-Se was a useful antioxidant that improved hepatocyte activity, growth performance, and anti-oxidation capacity in hepatocytes (in vitro) and SPF chicken (in vivo) by activating the TXNRD system.

Loading Effect of Chitosan Derivative Nanoparticles on Different Antigens and Their Immunomodulatory Activity on Dendritic Cells.

Drug carrier nanoparticles (NPs) were prepared by the polyelectrolyte method, with chitosan sulfate, with different substituents and quaternary ammonium chitosan, including C236-HACC NPs, C36-HACC NPs, and C6-HACC NPs. To evaluate whether the NPs are suitable for loading different antigens, we chose bovine serum albumin (BSA), ovalbumin (OVA), and myoglobin (Mb) as model antigens to investigate the encapsulation effect of the NPs. The characteristics (size, potential, and encapsulation efficiency) of the NPs were measured. Moreover, the NPs with higher encapsulation efficiency were selected for the immunological activity research. The results showed that chitosan derivative NPs with different substitution sites had different loading effects on the three antigens, and the encapsulation rate of BSA and OVA was significantly better than that of Mb. Moreover, the NPs encapsulated with different antigens have different immune stimulating abilities to DCS cells, the immune effect of OVA-coated NPs was significantly better than that of BSA-coated NPs and blank NPs, especially C236-HACC-OVA NPs. Furthermore, we found that C236-HACC-OVA NPs could increase the phosphorylation level of intracellular proteins to activate cell pathways. Therefore, C236-HACC NPs are more suitable for the loading of antigens similar to the OVA structure.

Chemical and biological characterization of sulfated chitosan oligomer as heparin mimics

In the present study, chitosan oligomer was modified to sulfated chitosan oligomer (ShCsO) to mimic heparin. Its chemical structure was determined by infrared spectroscopy (FT-IR), X-ray diffractometry (XRD), differential scanning calorimetry (DSC), and thermogravimetric analysis. The results showed that the FT-IR spectrum band at 799 cm−1corresponds to C–O–S and that at 1212 cm−1corresponds to S=O bond stretching, which prove that the sulfate groups are incorporated into chitosan oligomer successfully. The antimicrobial activity of ShCsO against to Bacillus subtilis in 1% concentration was 89.1 ± 1.7% . The IC50 (μg/ml) of ShCsO was 67.75, 56.07, 85.47, and 84.68 for A2780, MCF-7, DU-145, and HepG2, respectively. The results show that this newly synthesized material is a potential candidate to heparin-like chitosan derivatives. According to the literature, it was the first time that chitosan oligomer was modified to mimic heparin.

Synthesis optimization, DFT and physicochemical study of chitosan sulfates

Chitosan is an important biologically active amino polysaccharide. Water-soluble sulfated chitosan derivatives are widely used as anticoagulant and antiviral drugs. In this study, new methods for sulfamic acid sulfation of chitosan in the presence of urea in 1,4-dioxane and in a deep eutectic solvent representing a mixture of sulfamic acid and urea have been proposed. Mathematical models of sulfation of chitosan in these systems have been built. The obtained sulfated chitosan derivatives have been investigated by Fourier-transform infrared spectroscopy, X-ray diffractometry, atomic force microscopy, gel permeation chromatography, elemental analysis, and the density functional theory. The introduction of the sulfate group into the chitosan molecule was proven by infrared spectroscopy. When using the sulfamic acid/urea mixture, side reactions of carbamation of chitosan have been observed. It has been established from the atomic force microscopy data that the sulfated chitosan film surface consists of spherical particles partially agglomerated with each other. According to the gel permeation chromatography data, sulfated chitosan obtained in different systems, but under the same conditions (temperature and time), has different molecular weight distributions. The molecular weight distribution curve of the sulfated chitosan obtained in the sulfamic acid‒urea‒1,4-dioxane system is significantly shifted to the high-molecular region (Mw ~ 36.6 kDa), while the sulfated chitosan obtained in the sulfamic acid/urea deep eutectic solvent (Mw ~ 27.2 kDa). The density functional theory calculation of chitosan sulfates in the B3LYP/6-31G(d, p) basis set have been made.

Synthesis of Chitosan Sulfate From Crab (Scylla serrata) and its application as adsorbent

Synthesis of chitosan sulfate from crab (Scylla Serrata) shell and its application as Remazol Yellow FG dye adsorbent has been studied. This experiment was conducted to study the effectiveness of chitin from crab shell to be converted into chitosan sulfate and to study the adsorption of chitosan sulfate by Remazol Yellow FG dye. Isolation of chitin from crab shell was done by deproteination and demineralization process. Chitin had been converted into chitosan using demineralization process. Chitosan sulfate was made by reacting chitosan with 1 M ammonium sulfate solution. Characterizations of the chitosan are involving determination of degree of deacetylation. Functional group of chitin, chitosan and chitosan sulfate were determined by FTIR spectroscopy. The dye adsorption of chitosan sulfate was analyzed with UV-Vis spectroscopy. The result showed that rendement of chitin, chitosan and chitosan sulphate were 28.57%, 52.5% and 92%. The degree of deacetilation of chitin and chitosan were 80 – 90% and 70 – 80%. Remazol Yellow FG was adsopr 76.5%.

Evaluation of antibacterial, teratogenicity and antibiofilm effect of sulfated chitosans extracted from marine waste against microorganism

Biofilms play a key role in infectious diseases, as they may form on the surface and persist after treatment with various antimicrobial agents. The Staphylococcus aureus, Klebsiella pneumoniae, S. typhimurium, P. aeruginosa, and Escherichia coli most frequently associated with medical devices. Chitosan sulphate from marine litter (SCH-MW) was extracted and the mineral components were determined using atomic absorption spectroscopy (AAS). The degree of deacetylation (DA) of SCH was predicted 50% and 33.3% in crab and shrimp waste respectively. The elucidation of the structure of the SCH-MW was portrayed using FT-IR and 1H-NMR spectroscopy. The molecular mass of SCH-MW was determined with Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF). The teratogenicity of SCH-MW was characterized by the zebrafish embryo (ZFE) model. Antimicrobial activity of SCH-MW was tested with the agar well diffusion method; the inhibitory effect of SCH-MW on biofilm formation was assessed in 96 flat well polystyrene plates. The result revealed that a low concentration of crab-sulfated chitosan inhibited bacterial growth and significantly reduced the anti-biofilm activity of gram-negative and gram-positive bacteria relatively to shrimp. It is potentially against the biofilm formation of pathogenic bacteria.

A tough polysaccharide-based cell-laden double-network hydrogel promotes articular cartilage tissue regeneration in rabbits

Hydrogels used for cartilage tissue engineering purposes must be designed to mimic the biological and physical features of the native extracellular matrix (ECM). Here, we developed three different types of physical and chemical chondro-inductive hydrogels with the controlled drug release ability based on sulfated alginate (SAlg) and chitosan (CS). Bioconjugation of catechol to SAlg (SAlg-Cat) resulted in formation of SAlg-Cat/CS hydrogels with higher mechanical stability than physical SAlg/CS hydrogel. In the chemical double-network hydrogel (DN/SAlg-Cat), the presence of catechol and amine groups within the network resulted in dynamic and reversible bonding with energy dissipation. Our DN/SAlg-Cat hydrogel with initial compressive modulus of 34.86 kPa exhibited adequate compressive strength (421.45 kPa), toughness (89.69 kJ/m3), ability to self-heal and recoverability, which could be exceptional for utilizing in a load-bearing tissue like cartilage. Among hydrogels, the DN/SAlg-Cat hydrogel displayed less degradation rate (6.81%) and higher mechanical stability (81% retention of stiffness) in the presence of lysozyme (15 μg/mL) during 21 days. Incorporation of the sulfate and catechol groups within these hydrogels mediated the sustained release of TGF-β1 and kartogenin (KGN) chondrogenic agents, and resulted in proper chondrogenesis of the encapsulated mesenchymal stem cell (MSC) and chondrocyte (CH) co-culture. The catechol-enriched hydrogels (SAlg-Cat/CS and DN/SAlg-Cat) showed better regeneration of full-thickness articular defects in rabbits after 12 weeks due to the high affinity of the catechol group for cell adhesion, tissue integration, and immobilization of the biological factors. Our results demonstrated a role for a biomimetic microenvironment in efficient chondrogenesis.

Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophages.

Notwithstanding the remarkable progress in the clinical treatment of ischemic disease, proangiogenic drugs mostly suffer from their abnormal angiogenesis and potential cancer risk, and currently, no off-the-shelf biomaterials can efficiently induce angiogenesis. Here, we reported that a semisynthetic sulfated chitosan (SCS) readily engaged anti-inflammatory macrophages and increased its secretion of endogenous vascular endothelial growth factor (VEGF) to induce angiogenesis in ischemia via a VEGF-VEGFR2 signaling pathway. The depletion of host macrophages abrogated VEGF secretion and vascularization in implants, and the inhibition of VEGF or VEGFR2 signaling also disrupted the macrophage-associated angiogenesis. In addition, in a macrophage-inhibited mouse model, SCS efficiently helped to recover the endogenous levels of VEGF and the number of CD31hiEmcnhi vessels in ischemia. Thus, both sulfated group and pentasaccharide sequence in SCS played an important role in directing the therapeutic angiogenesis, indicating that this highly bioactive biomaterial can be harnessed to treat ischemic disease.

Designing, Preparation, and Evaluation of Orodispersible Chitosan Anionic Salt Tablets

Oral dispersible tablets (ODTs) are promising pharmaceutical dosage forms and, theoretically, could be used for many active pharmaceutical ingredients. The development of ODTs by direct compression with rapid disintegration and suitable hardness is a formulation challenge. The hypothesis of the present work is to prepare a single super-disintegrant multifunctional excipient for the production of ODTs. A single multifunctional tablet component was prepared by crosslinking of chitosan-hydrochloride (CS-H) using multivalent anionic salts, such as carbonate, phosphate, and sulfate. An optimized tablet characteristic concerning the disintegration time (DT) and the compaction properties is obtained utilizing the response surface methodology (RSM). The DT and elastic ratio (ER) were used as responses, and two other factors were studied, i.e., concentration of anions (Csa) and compression pressure (Pc). The obtained crosslinked chitosan anionic salt powders were also characterized in terms of chemical interaction, flowability, moisture uptake, water sorption, and release behavior of an incorporated chemically reactive model drug (ibuprofen lysinate). Based on RSM, the optimal concentrations of chitosan phosphate and chitosan sulfate (as %) were 61.14, 60.89, and 64.65, respectively. The optimal compression pressures (in Mpa) of chitosan carbonate, phosphate, and sulfate were 107.02, 110.39, and 100, respectively. Moreover, 0.31, 0.15, and 0.47 (predicted elastic ratio) and 8, 17, and 2 (disintegration time, s) were obtained for chitosan carbonate, phosphate, and sulfate, respectively. The infrared spectroscopy and the differential scanning microscopy studies were used as tools to detect the interaction. Mean dissolution time was 20.5 min for chitosan hydrochloride compared with 6.9–8.52 for chitosan anionic salts, while the dissolution efficiency was 0.54 for chitosan compared with > 0.8 for chitosan anionic salts. Drug release was higher from chitosan anionic salt matrix systems compared with that of chitosan hydrochloride tablets. The RSM was successfully utilized to prepare optimized tablets using chitosan anionic salt as a single oral dispersible tablet excipient. These salts exhibited suitable physico-mechanical properties upon compaction with a concomitant super-disintegration ability. The chemical reactivity of chitosan hydrochloride against negatively charged molecules was dependent upon crosslinking with negatively charged anions as indicated by the release behavior of ibuprofen lysinate from the chitosan anionic salt matrix systems.

Sulfated chitosan rescues dysfunctional macrophages and accelerates wound healing in diabetic mice

Emerging evidence suggests that dysfunctional macrophages can cause chronic inflammation and impair tissue regeneration in diabetic wounds. Therefore, improving macrophage behaviors and functions may improve therapeutic outcomes of current treatments in diabetic wounds. Herein, we present a sulfated chitosan (SCS)-doped Collagen type I (Col I/SCS) hydrogel as a candidate for diabetic wound treatments, and assess its efficacy using streptozocin (STZ)-induced diabetic wound model. Results showed that Col I/SCS hydrogel significantly improved wound closure rate, collagen deposition, and revascularization in diabetic wounds. Flow cytometry analysis and immunofluorescent staining analysis showed that the Col I/SCS hydrogel accelerated the resolution of excessive inflammation by reducing the polarization of M1-like macrophages in chronic diabetic wounds. In addition, ELISA analysis revealed that the Col I/SCS hydrogel reduced the production of pro-inflammatory interleukin (IL)-6 and increased the production of anti-inflammatory cytokines including IL-4 and transforming growth factor-beta 1 (TGF-β1) during wound healing. Moreover, the Col I/SCS hydrogel enhanced the transdifferentiation of macrophages into fibroblasts, which enhanced the formation of collagen and the extracellular matrix (ECM) in wound tissue. We highlight a potential application of manipulating macrophages behaviors in the pathological microenvironment via materials strategy. Statement of SignificanceImproving the chronic inflammatory microenvironment of diabetic wounds by regulating macrophage behaviors has been of wide concern in recent years. We designed a Col I/SCS hydrogel based on Collagen type I and sulfated chitosan (SCS) without exogenous cells or cytokines, which could significantly improve angiogenesis and resolve chronic inflammation in diabetic wounds, and hence accelerate diabetic wound healing. The Col I/SCS hydrogel could facilitate the polarization of M1-to-M2 macrophages and activate the transdifferentiation of macrophages to fibroblasts. Additionally, the Col I/SCS hydrogel also equilibrated the content of pro-inflammatory and anti-inflammatory cytokines. This strategy may afford a new avenue to improve macrophage functions and accelerate diabetic chronic wound healing.

Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells

In this study, we synthesized negatively charged chitosan sulfate and positively charged hydroxypropyltrimethyl ammonium chloride chitosan (HACC), and then prepared chitosan derivatives with positive and negative ions as nanoparticles (NPs) by ovalbumin encapsulation using the polyelectrolyte method. NPs with different substitution sites and molecular weights (MW) were prepared by varying conditions. We then determined the zeta potential average, diameter, encapsulation effect, and their immunostimulatory effects on dendritic cells (DCs). The results showed that chitosan-derivative NPs ranged in size from 153.33 to 320.90 nm; all NPs were positive, with charges ranging from 17.10 to 39.30 mV and the encapsulation rates of 65 %–75 %. Three NPs greatly promoted the expression and secretion of interleukin-6 (IL-6), tumor necrosis factor (TNF-α), and interleukin-1β (IL-1β) in DC cells: C2,3,6 chitosan sulfate-HACC (C2,3,6-HACC; 200 kDa), C3,6 chitosan sulfate-HACC (C3,6-HACC; 200 kDa) and C6 chitosan sulfate-HACC (C6-HACC; 50 kDa). We also found that 200-kDa C2,3,6-HACC and 50-kDa C6-HACC NPs greatly increased secretion of the major histocompatibility complex-II (MHC-II), CD40, CD80, and CD86, indicating that these NPs promote effective antigen presentation, further increasing immunity effects. Finally, we applied laser confocal photography and determined that NPs entered the cell to promote the regulation of cellular immune activity; this discovery lays a foundation for further research on their mechanism of their action. Therefore, C2,3,6-HACC and C6-HACC NPs have the potential as immunological adjuvants.

Synthesis, Characterization, and Properties of Sulfonated Chitosan for Protein Adsorption

Chitosan sulfate was prepared and characterized as a new chromatography media for protein separation. The degree of sulfonation of chitosan could be well controlled and impacted under conditions in the synthesis process. The prepared chitosan sulfate shows improved binding capacity with proteins. Sulfonated chitosan shows improved ion-exchange adsorption properties with proteins, which could have good potential in protein purification.

A three-dimensional crosslinked chitosan sulfate network binder for high-performance Li–S batteries

Abstract Poor cycling performance caused by the shuttle effect of polysulfides is the main obstacle in the development of advanced lithium–sulfur (Li–S) batteries. Functional polymer binders with polar groups can effectively adsorb polysulfides chemically, thereby suppressing the shuttle effect. Herein, a robust three-dimensional crosslinked polymer network, which demonstrates excellent mechanical property and strong affinity for polysulfides, is prepared by the aldimine condensation and coordination reactions. The crosslinked chitosan sulfate network (CCSN) significantly enhances the cycling performance and rate capability of the sulfur cathode. The CCSN-based sulfur cathode exhibits a high initial discharge capacity of 824 mAh g-1 with only 0.082% average capacity loss per cycle at 1 C. At a high rate of 4 C, the cathode exhibits a high capacity retention of 84.8% after 300 cycles. Moreover, the CCSN-based sulfur cathode exhibits an excellent cycling performance at a high sulfur loading of 2.5 mg cm-2, which indicates the excellent mechanical strength and binding performance of the CCSN binder for high-energy density Li–S batteries. This study demonstrates a viable approach for developing high-performance Li–S batteries for practical application.

Antithrombin III-mediated blood coagulation inhibitory activity of chitosan sulfate derivatized with different functional groups

Acylated chitosan sulfate (ChS1), a sulfated polysaccharide with high anticoagulant activity, was chemically synthesized and structurally characterized using FT-IR analysis. The beneficial structural properties and high availability of the sulfate group in ChS1 led to greater anticoagulant activity through both the intrinsic and common pathways with antithrombin III (AT III)-mediated inhibition, particularly involving coagulation factors FXa and FIIa. The analysis of the binding affinities using surface plasma resonance found that the equilibrium dissociation constant (KD) of ChS1 for FXa and FIIa in the presence of AT III was 67.4 nM and 112.6 nM, respectively, indicating the stronger interaction of the AT III/ChS1 complex with the ligands and the inhibition of activated FX and FII. The results of amidolytic assays further demonstrated the stronger inhibition of the proteolytic conversion of factor X by the intrinsic FXase complex and of FII by the prothrombinase complex. Molecular docking analysis further validated the protein-ligand interactions of ChS1 with AT III and their binding affinity.

Chitosan/dextran sulphate sodium hydrogels for wound healing material: preparation, characterisation and in vitro evaluation

ABSTRACT In recent years, the usage of hydrogels in tissue regeneration and controlled drug release systems have been increasing rapidly due to their water holding capacity and 3D structure. In this study chitosan and dextran sulphate sodium were prefered to form pH-sensitive hydrogel by physical interaction. The biodegradability of the chitosan and the therapeutic properties of dextran sulphate sodium make them suitable as wound dressing material. In addition to these good specifications of polymers, vitamin-C and quercetin, which have an accelerating effect on wound healing. The structural and morphological characterisation of hydrogels were performed by FT-IR and SEM. The sweeling behaviour of this hydrogel was examined in PBS at different temperatures (25°C and 37°C) and pHs (6,7,7.4,8). In vitro release pattern of quercetin and vitamin-C were investigated. It was seen from this experiment that at the end of the 7 days, cell viability on loaded and unloaded hydrogel were higher than control group.

Tailored covalently cross-linked hydrogels based on oxidized cellulose sulfate and carboxymethyl chitosan by targeted adjustment of the storage modulus

In general hydrogel synthesis uses a trial and error method when creating new hydrogels and searches afterwards for a fitting application of the received hydrogel. A much more effective and sustainable approach would be to have an application in mind before starting a targeted synthesis of a hydrogel with specific properties. Hence the goal of the study is to investigate influencing factors—crosslink density here represented through the degree of substitution, mass average molecular mass, mixing ratio and time for gelation—to the storage modulus G' for covalently cross-linked hydrogels based on oxidized cellulose sulfate and carboxymethyl chitosan. The results can be summarized as follows: higher values for G' can be reached by increasing the mass average molecular mass, the crosslink density and by shifting the mixing ratio toward the polymer which determines the number of possible cross-linkings in the hydrogel. The findings of this work may be transferred to similar systems and are helpful for a targeted synthesis of hydrogels with specific characteristics.

Different influence of sulfated chitosan with different sulfonic acid group sites on HUVECs behaviors

The vascularization within the scaffold is still a significant challenge in tissue engineering applications. Sulfated chitosan (SCS) as an amazing substance have been used in tissue engineering to stimulate angiogenesis. However, it is not clear whether they have difference in the ability to promote vascularization of SCS with different sulfonic acid group sites. The aim of this study was to evaluate human umbilical vein endothelial cells (HUVECs) viability and differentiation in vitro, affected by three types of sulfated chitosan’ i.e. 2-N-6-O-sulfated chitosan (2,6-SCS), 3’6-O-sulfated chitosan (3,6-SCS) and 6-O-sulfated chitosan (6-SCS). The results are showed that all the SCS possesses excellent biological properties to promote HUVECs viability and proliferation. Especially, 2,6-SCS promotes desirable intracellular nitric oxide secretion and capillary tube formation. Meanwhile, 2,6-SCS up-regulate the related gene and protein expression compared with other sulfonic acid group sites SCS and heparin. Therefore, 2,6-SCS is a promising substitute material for angiogenesis and as aqueous formulation can be employed to fabrication functionalization scaffold surface with promoted angiogenesis.